CTMG, Inc. logo — company profile

CTMG, Inc.

Founded 2004 United States Greenville, United States 9 employees Venture round Total: $6.84M Biotechnology, Health Care

General Information

Company Name CTMG, Inc.
Founded Year 2004
Location United States Greenville, United States
Employees 9
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with CTMG, Inc.. To contact CTMG, Inc., visit ctmginc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CTMG, Inc.

CTMG, Inc. is a biotechnology and healthcare company based in the United States, founded in 2004. The company specializes in conducting sponsored clinical trials and boasts unparalleled speed and data certainty in completing trials within forecast timelines. CTMG achieves this through its unique business structure, partnering with Network Physician Investigative Sites and employing the world’s first cGMP-like processes to translate specific protocol requirements into measurable steps. Real-time quality systems are in place to ensure data collection at Business Associate physician sites, enabling the identification of operational barriers and rapid solution formation. CTMG’s Adaptive Investigative Site Management® service has demonstrated remarkable success in maximizing Investigative Site Performance across various therapeutic areas. The company's achievements between 2011-13 include significantly higher Investigative Site enrollment compared to non-CTMG sites, with superior data quality leading to FDA Approval or FDA Recommendation for Approval for test articles. CTMG's methodology garnered attention from the FDA, with company representatives presenting its approach to FDA divisions. The CEO also published the advantages of CTMG’s approach in the Food and Drug Law Institute’s Food and Drug Policy Forum. In August 2016, CTMG secured a noteworthy $2.37M Venture Round investment. The absence of disclosed investors may indicate the company's ability to attract funding independently or from non-traditional sources. CTMG's innovative approach to clinical trial management, proven track record, and ability to secure significant investments position it as a promising player in the biotechnology and healthcare industries, with potential for further growth and impact.

Taxonomy: clinical trial management, data certainty, biopharmaceuticals, FDA approval, investigative site performance, therapeutic areas, cGMP-like processes, Sponsored clinical trials, real time quality systems, physician investigative sites, patient enrollment, FDA regulations, clinical research, medical data collection, drug development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.37M -
12 Aug 2016
Venture Round $454.68K -
04 Mar 2015
Venture Round $3.02M -
06 Nov 2013
Venture Round $1.00M -
23 Jul 2009

CTMG, Inc. Alternatives & Competitors

View All Alternatives
CTMG, Inc. vs

Committed to contributing to the advancement of medicine and curing diseases in an ethical and safe...

20 employees
Biotechnology, Health Care
CTMG, Inc. vs

Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® tech...

Debt Financing
316 employees
Biotechnology, Health Care
CTMG, Inc. vs

Moving Forward. Together.

17 employees
Biotechnology, Health Care

FAQ About CTMG, Inc.

CTMG, Inc. provides unparalleled speed and data certainty in completing Sponsored clinical trials per originally forecast timelines. We accomplish this through our unique business structure of partnering with our Network Physician Investigative Sites, and providing the world’s first cGMP-like proces...
CTMG, Inc. was founded in 2004.
CTMG, Inc. is headquartered in Greenville, United States.
CTMG, Inc. operates in Biotechnology and Health Care. Its work centres on clinical trial management, data certainty, biopharmaceuticals and FDA approval.
CTMG, Inc. has approximately 9 employees.
CTMG, Inc. has completed 4 funding rounds, raising a total of $6.84M. The latest funding stage is Venture round.
Top alternatives and competitors to CTMG, Inc. include Ventavia Research Group, Elligo Health Research, Physicians Research Group, D2V Clinical, Meridien Research. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CTMG, Inc. and Ventavia Research Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CTMG, Inc., https://bouncewatch.com/company/ctmg-inc, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes